相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chimeric antigen receptor T cells: a novel therapy for solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The growing world of CAR T cell trials: a systematic review
Astrid Holzinger et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
HER2 testing in gastric cancer: An update
Lucas Faria Abrahao-Machado et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Targeting folate receptor alpha for cancer treatment
Anthony Cheung et al.
ONCOTARGET (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside
Qi Zhang et al.
ONCOIMMUNOLOGY (2016)
Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications
Ignace B. Vergote et al.
CANCER AND METASTASIS REVIEWS (2015)
Utilizing chimeric antigen receptors to direct natural killer cell activity
David L. Hermanson et al.
FRONTIERS IN IMMUNOLOGY (2015)
Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer
Yunfei Wen et al.
CLINICAL CANCER RESEARCH (2015)
Selective Bispecific T Cell Recruiting Antibody and Antitumor Activity of Adoptive T Cell Transfer
Sebastian Kobold et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schönfeld et al.
MOLECULAR THERAPY (2014)
Adoptive Immunotherapy for Cancer or Viruses
Marcela V. Maus et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
CAR T Cells for Solid Tumors Armed and Ready to Go?
Sunitha Kakarla et al.
CANCER JOURNAL (2014)
Characteristics of gastric cancer in Asia
Rubayat Rahman et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
V. S. Warneke et al.
BRITISH JOURNAL OF CANCER (2013)
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
JianMin Lin et al.
CANCER BIOLOGY & THERAPY (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Advances in the development of cancer. immunotherapies
Jianjun Gao et al.
TRENDS IN IMMUNOLOGY (2013)
Retargeting NK-92 cells by means of CD19-and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
Laurent Boissel et al.
ONCOIMMUNOLOGY (2013)
Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro
B. A. Kamen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Paradoxical Impact of Two Folate Receptors, FRα and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome
Michelle K. Y. Siu et al.
PLOS ONE (2012)
Nuclear localization of folate receptor alpha: a new role as a transcription factor
Vanda Boshnjaku et al.
SCIENTIFIC REPORTS (2012)
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
Marc Cartellieri et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
ZAP-70: An Essential Kinase in T-cell Signaling
Haopeng Wang et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
CAR Mechanics: Driving T Cells into the MUC of Cancer
John Maher et al.
CANCER RESEARCH (2009)
Folate-targeted therapeutic and imaging agents for cancer
Philip Stewart Low et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts
Renier J. Brentjens et al.
CLINICAL CANCER RESEARCH (2007)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Role of folate receptor genes in reproduction and related cancers
H Elnakat et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity
G Suck et al.
EXPERIMENTAL HEMATOLOGY (2005)
Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase
Y Taguchi et al.
BLOOD (2004)
T-cell activation by recombinant immunoreceptors:: Impact of the intracellular signalling domain on the stability of receptor expression and antigen-specific activation of grafted T cells
C Heuser et al.
GENE THERAPY (2003)
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation
NM Haynes et al.
JOURNAL OF IMMUNOLOGY (2002)
Cytotoxic T lymphocytes: All roads lead to death
M Barry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Redirecting mouse CTL against colon carcinoma: Superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma
NM Haynes et al.
JOURNAL OF IMMUNOLOGY (2001)
Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: The dynamics of T-cell proliferation and death
EJ Beecham et al.
JOURNAL OF IMMUNOTHERAPY (2000)
分享论文
